| | | 57771 | | 22.12.2006 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 02.07.20. | | | | 02.07.20. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Exforge 5/80 mg | Filmtabletten | Coated tablets (Amlodipine 5 mg, Valsartan 80 mg) | C09DB01 | CI | | 02 | Exforge 5/160 mg | Filmtabletten | Coated tablets (Amlodipine 5 mg, Valsartan 160 mg) | C09DB01 | CI | | 03 | Exforge 10/160 mg | Filmtabletten | Coated tablets (Amlodipine 10 mg, Valsartan 160 mg) | C09DB01 | CI |
|
|
